{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T02:57:44Z","timestamp":1782701864720,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Network of Depression Centers"},{"DOI":"10.13039\/100019310","name":"Feinstein Institutes for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019310","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioPsychoSocial Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Prevalence of premenstrual syndrome (PMS) may be as high as 13-18%, but it remains under-recognized and is associated with increased suicidal ideation (SI), plans, and attempts in epidemiological studies. The present study reports on women endorsing premenstrual SI (PMSI) and characterizes this at-risk group and its clinical correlates.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cross-sectional study assessed demographics, anxiety and depression severity, psychiatric diagnoses, menstrual symptoms, SI, and trauma in adult women at a major medical center over 11 months.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Three hundred two women were assessed. Of 153 participants endorsing premenstrual symptoms, 41 (27%) reported new or worsening concurrent premenstrual passive or active SI. Women who reported PMSI were significantly more likely to be single, unemployed, and childless as well as significantly more likely to report interference from premenstrual symptoms, histories of psychiatric hospitalization, adverse childhood events, suicide attempts, and current and past depression and anxiety compared to women without PMSI. The final regression model indicated the most significant predictors of PMSI were history of a depression diagnosis, severity of current depressive symptoms, and having experienced 3 or more childhood adverse events.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Nearly one-third of women reporting premenstrual symptoms endorsed concurrent SI, a clinically valuable demonstration of the importance of this predictable cyclic risk factor.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13030-022-00252-3","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T16:17:32Z","timestamp":1667924252000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical correlates of women endorsing premenstrual suicidal ideation: a cross-sectional study"],"prefix":"10.1186","volume":"16","author":[{"given":"Sara V.","family":"Carlini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra J.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Mordukhaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunu","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather A.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7439-2236","authenticated-orcid":false,"given":"Kristina M.","family":"Deligiannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"issue":"1","key":"252_CR1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ajog.2017.05.045","volume":"218","author":"KA Yonkers","year":"2018","unstructured":"Yonkers KA, Simoni MK. Premenstrual disorders. Am J Obstet Gynecol. 2018;218(1):68\u201374.","journal-title":"Am J Obstet Gynecol"},{"key":"252_CR2","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC:\u00a0American Psychiatric Association; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"Suppl 3","key":"252_CR3","first-page":"1","volume":"28","author":"U Halbreich","year":"2003","unstructured":"Halbreich U, Borenstein J, Pearlstein T, Kahn LS. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS\/PMDD). Psychoneuroendocrinology. 2003;28(Suppl 3):1\u201323.","journal-title":"Psychoneuroendocrinology."},{"issue":"12","key":"252_CR4","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1089\/jwh.2021.0185","volume":"30","author":"D Prasad","year":"2021","unstructured":"Prasad D, Wollenhaupt-Aguiar B, Kidd KN, de Azevedo CT, Frey BN. Suicidal risk in women with premenstrual syndrome and premenstrual dysphoric disorder: a systematic review and Meta-analysis. J Women\u2019s Heal (Larchmt). 2021;30(12):1693\u2013707.","journal-title":"J Women\u2019s Heal (Larchmt)."},{"key":"252_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jad.2021.08.082","volume":"295","author":"H Yan","year":"2021","unstructured":"Yan H, Ding Y, Guo W. Suicidality in patients with premenstrual dysphoric disorder\u2013a systematic review and meta-analysis. J Affect Disord. 2021;295:339\u201346.","journal-title":"J Affect Disord"},{"issue":"10","key":"252_CR6","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1176\/appi.ajp.2017.16101113","volume":"174","author":"PJ Schmidt","year":"2017","unstructured":"Schmidt PJ, Martinez PE, Nieman LK, et al. Premenstrual dysphoric disorder symptoms following ovarian suppression: triggered by change in ovarian steroid levels but not continuous stable levels. Am J Psychiatry. 2017;174(10):980\u20139.","journal-title":"Am J Psychiatry"},{"issue":"6","key":"252_CR7","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/00006842-198312000-00004","volume":"45","author":"T B\u00e4ckstr\u00f6m","year":"1983","unstructured":"B\u00e4ckstr\u00f6m T, Sanders D, Leask R, Davidson D, Warner P, Bancroft J. Mood, sexuality, hormones, and the menstrual cycle. II. Hormone levels and their relationship to the premenstrual syndrome. Psychosom Med. 1983;45(6):503\u20137.","journal-title":"Psychosom Med"},{"issue":"11","key":"252_CR8","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s00213-016-4258-1","volume":"233","author":"E Timby","year":"2016","unstructured":"Timby E, B\u00e4ckstr\u00f6m T, Nyberg S, Stenlund H, Wihlb\u00e4ck ACN, Bixo M. Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls\u2014a pilot study. Psychopharmacology. 2016;233(11):2109\u201317.","journal-title":"Psychopharmacology."},{"key":"252_CR9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.psyneuen.2016.01.026","volume":"67","author":"TA Eisenlohr-Moul","year":"2016","unstructured":"Eisenlohr-Moul TA, Rubinow DR, Schiller CE, Johnson JL, Leserman J, Girdler SS. Histories of abuse predict stronger within-person covariation of ovarian steroids and mood symptoms in women with menstrually related mood disorder. Psychoneuroendocrinology. 2016;67:142\u201352.","journal-title":"Psychoneuroendocrinology."},{"issue":"8","key":"252_CR10","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1080\/00981389.2020.1823547","volume":"59","author":"CA LaBrenz","year":"2020","unstructured":"LaBrenz CA, O\u2019Gara JL, Panisch LS, Baiden P, Larkin H. Adverse childhood experiences and mental and physical health disparities: the moderating effect of race and implications for social work. Soc work Health Care. 2020;59(8):588\u2013614.","journal-title":"Soc work Health Care."},{"issue":"1","key":"252_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1089\/jwh.2016.6261","volume":"27","author":"HA Flynn","year":"2018","unstructured":"Flynn HA, Spino C, Guille C, et al. A collaborative, network-based approach to advance Women\u2019s depression research in the United States: preliminary findings. J Women\u2019s Heal (Larchmt). 2018;27(1):51\u20137.","journal-title":"J Women\u2019s Heal (Larchmt)"},{"key":"252_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jad.2021.08.013","volume":"295","author":"SJ Weiss","year":"2021","unstructured":"Weiss SJ, Flynn H, Christian L, et al. Symptom profiles of women at risk of mood disorders: a latent class analysis. J Affect Disord. 2021;295:139\u201347.","journal-title":"J Affect Disord"},{"issue":"3","key":"252_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/MLR.0b013e318160d093","volume":"46","author":"B L\u00f6we","year":"2008","unstructured":"L\u00f6we B, Decker O, M\u00fcller S, et al. Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population. Med Care. 2008;46(3):266\u201374.","journal-title":"Med Care"},{"issue":"9","key":"252_CR14","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JBW. The PHQ-9. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"issue":"4","key":"252_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0749-3797(98)00017-8","volume":"14","author":"VJ Felitti","year":"1998","unstructured":"Felitti VJ, Anda RF, Nordenberg D, et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The adverse childhood experiences (ACE) study. Am J Prev Med. 1998;14(4):245\u201358.","journal-title":"Am J Prev Med"},{"issue":"2","key":"252_CR16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"key":"252_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.","journal-title":"J Biomed Inform"},{"issue":"1","key":"252_CR18","first-page":"1","volume":"55","author":"MB Wilk","year":"1968","unstructured":"Wilk MB, Gnanadesikan R. Probability plotting methods for the analysis for the analysis of data. Biometrika. 1968;55(1):1\u201317.","journal-title":"Biometrika."},{"issue":"3-4","key":"252_CR19","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/biomet\/52.3-4.591","volume":"52","author":"SS Shapiro","year":"1965","unstructured":"Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika. 1965;52(3-4):591\u2013611.","journal-title":"Biometrika."},{"issue":"1","key":"252_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1214\/aoms\/1177730491","volume":"18","author":"HB Mann","year":"1947","unstructured":"Mann HB, Whitney DR. On a test of whether one of two random variables is stochastically larger than the other. Ann Math Stat. 1947;18(1):50\u201360.","journal-title":"Ann Math Stat"},{"key":"252_CR21","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1998","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. New York: Routledge Academic; 1998."},{"key":"252_CR22","volume-title":"Handbook of regression analysis","author":"S Chatterjee","year":"2013","unstructured":"Chatterjee S, Simonoff J. Handbook of regression analysis. New York: Wiley; 2013."},{"issue":"5","key":"252_CR23","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1177\/0013164418817803","volume":"79","author":"KM Marcoulides","year":"2019","unstructured":"Marcoulides KM, Raykov T. Evaluation of variance inflation factors in regression models using latent variable modeling methods. Educ Psychol Meas. 2019;79(5):874\u201382.","journal-title":"Educ Psychol Meas"},{"issue":"3","key":"252_CR24","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00127-012-0548-z","volume":"48","author":"CE Pilver","year":"2013","unstructured":"Pilver CE, Libby DJ, Hoff RA. Premenstrual dysphoric disorder as a correlate of suicidal ideation, plans, and attempts among a nationally representative sample. Soc Psychiatry Psychiatr Epidemiol. 2013;48(3):437\u201346.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"1","key":"252_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12905-022-01612-5","volume":"22","author":"A Wikman","year":"2022","unstructured":"Wikman A, Sacher J, Bixo M, et al. Prevalence and correlates of current suicidal ideation in women with premenstrual dysphoric disorder. BMC Womens Health. 2022;22(1):35.","journal-title":"BMC Womens Health"},{"issue":"2","key":"252_CR26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00737-020-01054-8","volume":"24","author":"E Osborn","year":"2021","unstructured":"Osborn E, Brooks J, O\u2019Brien PMS, Wittkowski A. Suicidality in women with premenstrual dysphoric disorder: a systematic literature review. Arch Womens Ment Health. 2021;24(2):173\u201384.","journal-title":"Arch Womens Ment Health."},{"key":"252_CR27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jpsychires.2022.09.033","volume":"155","author":"SJ Weiss","year":"2022","unstructured":"Weiss SJ, Simeonova DI, Koleva H, et al. Potential paths to suicidal ideation and suicide attempts among high-risk women. J Psychiatr Res. 2022;155:493\u2013500.","journal-title":"J Psychiatr Res."}],"container-title":["BioPsychoSocial Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13030-022-00252-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13030-022-00252-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13030-022-00252-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T02:03:33Z","timestamp":1667959413000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpsmedicine.biomedcentral.com\/articles\/10.1186\/s13030-022-00252-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["252"],"URL":"https:\/\/doi.org\/10.1186\/s13030-022-00252-3","relation":{},"ISSN":["1751-0759"],"issn-type":[{"value":"1751-0759","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,8]]},"assertion":[{"value":"30 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"the present study protocol, IRB # 18-0107, was deemed exempt under 45 CFR 46.101(b)(2) by the Institutional Review Board of the Office of the Human Research Protection Program at Northwell Health, FWA #00002505.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there are no conflicts of interests. Dr. Deligiannidis receives separate research grant support from the National Institutes of Health (R01MH120313), Sage Therapeutics, and Vorso Corporation, serves as a consultant to Sage Therapeutics and Brii Biosciences, and receives royalties from an National Institutes of Health Employee Invention. During the course of this study, Dr. Weiss received separate research funding from the National Institutes of Health (R01HD081188, R01HD084813, T32NR016920) and the Robert and Delphine Wentland Eschbach Endowment.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}